Loading…
20,252 grants found
Showing 1,781 – 1,800 of 20,252 grants
PROJECT ABSTRACT Tobacco use has alarmingly high rates among people with HIV (PWH), 43% compared with 15% in the general population. Due to the development of highly effective trea...
ABSTRACT Chromosome rearrangements (structural variants) are common in cancer and they drive tumor development by altering the expression or function of oncogenes and tumor suppres...
Abstract Immunotherapies for cancer, including Adoptive Cell Transfer (ACT), chimeric antigen receptor (CAR) T cell therapy, and Immune Checkpoint Blockade (ICB), have seen great c...
PROJECT SUMMARY / ABSTRACT CRISPR technology have massively expanded our ability to interrogate the genetic mechanisms of cancer and define therapeutic avenues. Techniques have evo...
Project Summary Obesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a cancer that has a dismal 5-year survival rate due to limitations in prevention and treatment...
Glioblastoma (GBM) is the most lethal of all brain malignancies and many patients die within one year of diagnosis. These poor outcomes are driven by GBM's aggressive growth,...
Project Summary/Abstract Tobacco smoking is causally related to at least 12 cancer types. Quitting smoking after cancer is critical for improved treatment outcomes; however, over t...
Abstract Ultra-high dose rate (UHDR) radiation delivery, termed FLASH radiotherapy (FLASH-RT), has the potential to reduce normal tissue damage, with significant clinical cancer tr...
PROJECT SUMMARY While cancer is known for its heterogeneity, with distinct subtypes observed within each organ system, the source of this heterogeneity, and the relationship betwee...
Abstract Prostate cancer is one of the most common cancers among men, and although it can successfully be treated in some men, others develop resistance to therapies and can relaps...
ABSTRACT Current cancer therapeutic vaccines that utilize both CD4 and CD8 T cell neoantigens to stimulate T cell immunity through dendritic cell/macrophage-mediated antigen presen...
Modern drug analysis techniques are an integral part of research and healthcare today. Regrettably, the current approach for sample collection consists of literally removing “a pie...
ABSTRACT Merkel cell carcinoma (MCC) is a poorly understood cutaneous malignancy with viral etiology. Most MCC tumors feature monoclonal integration of Merkel cell polyomavirus (MC...
Abstract Pancreatic cancer is a slow-growing disease with a 5-year survival rate of approximately 9%. It is the fourth leading cause of cancer-related deaths in the US. Currently u...
Summary Chimeric Antigen Receptor (CAR)-T cell therapies have achieved unprecedented success in treating blood cancers that are resistant to traditional radiation or chemotherapies...
Project Summary Disruption of normal mitochondrial bioenergetics and oxidative phosphorylation represents an early event during oncogenesis by changing the energy metabolism of pre...
Project Summary The overall incidence of thyroid cancer in 2016 was estimated by the National Cancer Institute to be 64,300. Patients who present with poorly differentiated thyroid...
PROJECT SUMMARY/ABSTRACT Unprecedented clinical successes in past 12-years with immune checkpoint blockers (ICBs) such as anti- CTLA-4 and anti-PD-1 re-instigate strong interests i...
Project Summary/Abstract Adoptive cellular therapies (ACTs) have made remarkable advances in the treatment of hematological malignancies. However, remarkable outcomes are confined...
PROJECT SUMMARY/ABSTRACT The overall goal of this project is to identify the role of the gut microbiome in the etiology of benign breast disease (BBD), and thereby shed light on it...